Fresenius Kabi's manufacturing hiccups multiplied as 2020 unfolded. Now, a little more than a week into the new year, the German drugmaker found its way onto the FDA's recall list once more, citing ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Please replace the captions with the accompanying corrected captions. The release reads: FRESENIUS KABI ISSUES VOLUNTARY NATIONWIDE RECALL OF 13 LOTS OF KETOROLAC ...

The FDA and American Regent have notified healthcare professionals of a voluntary nationwide recall of all lots of its ketorolac tromethamine injection 30mg/mL. This recall is due to the potential ...

In light of the recent nationwide shortage of Ketorolac Tromethamine Injection, Regency Therapeutics, a division of Luitpold Pharmaceuticals, is alerting surgery centers, hospitals and health systems ...

Credit: Thinkstock. Compared to higher doses, 10mg of intravenous (IV) ketorolac (analgesic ceiling dose) provided effective pain relief without increased adverse effects in emergency department (ED) ...

Please provide your email address to receive an email when new articles are posted on . MAUI, Hawaii — A new formulation of ketorolac tromethamine treats the ocular pain associated with ...

October 22, 2009 — American Regent has issued a voluntary recall of all lots of ketorolac tromethamine injection, 30 mg/mL, the US Food and Drug Administration (FDA) announced yesterday. Particulate ...

The authors evaluated the effect of polymer composition on the drug-release profile and the effect of storage conditions on dissolution characteristics. Ketorolac tromethamine (KT), ...

Fresenius Kabi USA, LLC is voluntarily recalling 13 lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL, 1 mL fill in a 2 mL amber vial and Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg ...